235735
Building internal capacity through a chronic disease prevention initiative
Sunday, October 30, 2011: 2:40 PM
The purpose of this presentation is to identify how to transform local public health agencies to strategically address chronic disease prevention with limited resources. This presentation will: - Highlight the creation of the Childhood Obesity Action Plan of 2006, a public-private partnership that supports Agency direction to prevent childhood obesity. - Discuss the adoption of the 3-4-50 concept to address chronic disease – that worldwide three risk factors contribute to four of the most prevalent chronic diseases and are responsible for over 50% of all deaths – led to an upstream approach to maximizing limited staff resources. - Discuss the “Place Matters” approach to addressing the root causes of chronic diseases. - Outline how to establish a Chronic Disease Agenda to reduce chronic disease and health disparities. - Share how local health agencies can build capacity and mobilize the public health workforce to prevent chronic disease.
Learning Areas:
Administration, management, leadership
Chronic disease management and prevention
Program planning
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives: 1. Explain how a “Place Matters” approach can be implemented to prevent chronic disease.
2. Identify two innovative partnerships to pursue to prevent chronic disease.
3. Describe how to activate and leverage multi-sectoral resources.
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am qualified to present on the content I am responsible for because I am the Public Health Officer for the County of San Diego Health and Human Services Agency.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|